Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 500 results in range #51 to #550.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. Radiological attack‏‎ (1 revision)
  2. ICRP Publication 25‏‎ (1 revision)
  3. Reactive oxygen species‏‎ (1 revision)
  4. ICRP Publication 31‏‎ (1 revision)
  5. Deterministic effect‏‎ (1 revision)
  6. Reference worker‏‎ (1 revision)
  7. ICRP Publication 46‏‎ (1 revision)
  8. ICRP Publication 92‏‎ (1 revision)
  9. ICRP Publication 60‏‎ (1 revision)
  10. Dose modifying factor‏‎ (1 revision)
  11. ICRP Publication 75‏‎ (1 revision)
  12. Informed consent‏‎ (1 revision)
  13. ICRP Publication 9‏‎ (1 revision)
  14. Spongiosa‏‎ (1 revision)
  15. 1934 Recommendations‏‎ (1 revision)
  16. Access control‏‎ (1 revision)
  17. Marrow cellularity‏‎ (1 revision)
  18. General Information: Radon‏‎ (1 revision - redirect page)
  19. Multitarget equation‏‎ (1 revision)
  20. ICRP Publication 108‏‎ (1 revision)
  21. Brachytherapy‏‎ (1 revision)
  22. Pilomatricoma‏‎ (1 revision)
  23. ICRP Publication 121‏‎ (1 revision)
  24. Case–control study‏‎ (1 revision)
  25. ICRP Publication 136‏‎ (1 revision)
  26. Collective dose‏‎ (1 revision)
  27. Radiation-induced secondary malignancy‏‎ (1 revision)
  28. ICRP Publication 151‏‎ (1 revision)
  29. Radiological controlled area‏‎ (1 revision)
  30. ICRP Publication 26‏‎ (1 revision)
  31. DS86‏‎ (1 revision)
  32. ICRP Publication 32‏‎ (1 revision)
  33. Referrer‏‎ (1 revision)
  34. ICRP Publication 47‏‎ (1 revision)
  35. ICRP Publication 93‏‎ (1 revision)
  36. ICRP Publication 61‏‎ (1 revision)
  37. ICRU 4-element tissue‏‎ (1 revision)
  38. ICRP Publication 76‏‎ (1 revision)
  39. Equilibrium equivalent concentration‏‎ (1 revision)
  40. Expanded radiation field‏‎ (1 revision)
  41. 1937 Recommendations‏‎ (1 revision)
  42. System of radiological protection‏‎ (1 revision)
  43. Time-resolved computed tomography‏‎ (1 revision)
  44. Adventitious source‏‎ (1 revision)
  45. Mutation component‏‎ (1 revision)
  46. Annual intake‏‎ (1 revision)
  47. Waste management‏‎ (1 revision)
  48. Normal tissue complication probability‏‎ (1 revision)
  49. ICRP Publication 109‏‎ (1 revision)
  50. ICRP Publication 122‏‎ (1 revision)
  51. ICRP Publication 137‏‎ (1 revision)
  52. ICRP Publication 152‏‎ (1 revision)
  53. ICRP Publication 27‏‎ (1 revision)
  54. ICRP Publication 33‏‎ (1 revision)
  55. Detriment-adjusted risk‏‎ (1 revision)
  56. Region‏‎ (1 revision)
  57. ICRP Publication 48‏‎ (1 revision)
  58. Dose-response function‏‎ (1 revision)
  59. ICRP Publication 94‏‎ (1 revision)
  60. ICRP Publication 62‏‎ (1 revision)
  61. ICRU sphere‏‎ (1 revision)
  62. ICRP Publication 77‏‎ (1 revision)
  63. Equilibrium factor‏‎ (1 revision)
  64. 1950 Recommendations‏‎ (1 revision)
  65. Treatment preparation in radiotherapy‏‎ (1 revision)
  66. Notification value‏‎ (1 revision)
  67. Backscatter factor‏‎ (1 revision)
  68. Other (systemic) tissues‏‎ (1 revision)
  69. ICRP Publication 10A‏‎ (1 revision)
  70. ICRP Publication 123‏‎ (1 revision)
  71. Charged-particle equilibrium‏‎ (1 revision)
  72. ICRP Publication 138‏‎ (1 revision)
  73. Collimation‏‎ (1 revision)
  74. ICRP Publication 153‏‎ (1 revision)
  75. ICRP Publication 28‏‎ (1 revision)
  76. ICRP Publication 34‏‎ (1 revision)
  77. Regional diagnostic reference levels‏‎ (1 revision)
  78. ICRP Publication 49‏‎ (1 revision)
  79. ICRP Publication 95‏‎ (1 revision)
  80. ICRP Publication 63‏‎ (1 revision)
  81. Sealed source‏‎ (1 revision)
  82. ICRP Publication 78‏‎ (1 revision)
  83. Elemental dose‏‎ (1 revision)
  84. Solar flare‏‎ (1 revision)
  85. Exposed individuals‏‎ (1 revision)
  86. 1954 Recommendations‏‎ (1 revision)
  87. Linear dose response‏‎ (1 revision)
  88. Mean glandular dose‏‎ (1 revision)
  89. Trophic level‏‎ (1 revision)
  90. Apoptosis‏‎ (1 revision)
  91. Nuclear medicine‏‎ (1 revision)
  92. ICRP Publication 11‏‎ (1 revision)
  93. Pooled analysis‏‎ (1 revision)
  94. ICRP Publication 124‏‎ (1 revision)
  95. ICRP Publication 139‏‎ (1 revision)
  96. Radiation risk‏‎ (1 revision)
  97. ICRP Publication 154‏‎ (1 revision)
  98. Cosmic radiation‏‎ (1 revision)
  99. ICRP Publication 29‏‎ (1 revision)
  100. ICRP Publication 35‏‎ (1 revision)
  101. Registry‏‎ (1 revision)
  102. ICRP Publication 5‏‎ (1 revision)
  103. Dose-threshold hypothesis‏‎ (1 revision)
  104. ICRP Publication 96‏‎ (1 revision)
  105. ICRP Publication 64‏‎ (1 revision)
  106. Secondary radiation‏‎ (1 revision)
  107. ICRP Publication 79‏‎ (1 revision)
  108. Intake‏‎ (1 revision)
  109. Standard-size adult‏‎ (1 revision)
  110. 1956 Recommendations‏‎ (1 revision)
  111. Activation‏‎ (1 revision)
  112. Tissue reaction‏‎ (1 revision)
  113. Measured quantity‏‎ (1 revision)
  114. Tumour suppressor gene‏‎ (1 revision)
  115. National DRL‏‎ (1 revision)
  116. ICRP Publication 1‏‎ (1 revision)
  117. Baseline disease rates‏‎ (1 revision)
  118. Oxygen enhancement ratio‏‎ (1 revision)
  119. ICRP Publication 110‏‎ (1 revision)
  120. Breakpoint cluster region/abelson‏‎ (1 revision)
  121. Population risk‏‎ (1 revision)
  122. ICRP Publication 125‏‎ (1 revision)
  123. ICRP Publication 14‏‎ (1 revision)
  124. Commissioning‏‎ (1 revision)
  125. ICRP Publication 155‏‎ (1 revision)
  126. ICRP Publication 3‏‎ (1 revision)
  127. Redox‏‎ (1 revision)
  128. ICRP Publication 36‏‎ (1 revision)
  129. Dicentric chromosome‏‎ (1 revision)
  130. ICRP Publication 50‏‎ (1 revision)
  131. Dose and dose-rate effectiveness factor‏‎ (1 revision)
  132. ICRP Publication 97‏‎ (1 revision)
  133. ICRP Publication 65‏‎ (1 revision)
  134. Secretory cells‏‎ (1 revision)
  135. ICRP Publication 8‏‎ (1 revision)
  136. Intensity-modulated radiotherapy‏‎ (1 revision)
  137. Stem cell‏‎ (1 revision)
  138. Kerma approximation‏‎ (1 revision)
  139. 1959 Decisions‏‎ (1 revision)
  140. National radon survey‏‎ (1 revision)
  141. Hereditary effect‏‎ (1 revision)
  142. ICRP Publication 10‏‎ (1 revision)
  143. ICRP Publication 111‏‎ (1 revision)
  144. Potential alpha energy concentration‏‎ (1 revision)
  145. ICRP Publication 126‏‎ (1 revision)
  146. ICRP Publication 140‏‎ (1 revision)
  147. ICRP Publication 16‏‎ (1 revision)
  148. ICRP Publication 30‏‎ (1 revision)
  149. Dental and maxillofacial imaging‏‎ (1 revision)
  150. ICRP Publication 37‏‎ (1 revision)
  151. Relative biological effectiveness‏‎ (1 revision)
  152. ICRP Publication 51‏‎ (1 revision)
  153. ICRP Publication 98‏‎ (1 revision)
  154. ICRP Publication 66‏‎ (1 revision)
  155. ICRP Publication 80‏‎ (1 revision)
  156. Somatic effect‏‎ (1 revision)
  157. Targeted effects‏‎ (1 revision)
  158. Active detection system‏‎ (1 revision)
  159. Typical value‏‎ (1 revision)
  160. ICRP Publication 100‏‎ (1 revision)
  161. Particle transport‏‎ (1 revision)
  162. ICRP Publication 112‏‎ (1 revision)
  163. ICRP Publication 127‏‎ (1 revision)
  164. ICRP Publication 141‏‎ (1 revision)
  165. ICRP Publication 17‏‎ (1 revision)
  166. Count median diameter‏‎ (1 revision)
  167. Radon-prone area‏‎ (1 revision)
  168. ICRP Publication 30 (Index)‏‎ (1 revision)
  169. Reference Person‏‎ (1 revision)
  170. ICRP Publication 38‏‎ (1 revision)
  171. Relative life lost‏‎ (1 revision)
  172. ICRP Publication 52‏‎ (1 revision)
  173. Dose commitment‏‎ (1 revision)
  174. ICRP Publication 99‏‎ (1 revision)
  175. ICRP Publication 67‏‎ (1 revision)
  176. Doubling dose‏‎ (1 revision)
  177. Security screening‏‎ (1 revision)
  178. ICRP Publication 81‏‎ (1 revision)
  179. Evacuation‏‎ (1 revision)
  180. Stochastic effect‏‎ (1 revision)
  181. Exposure index‏‎ (1 revision)
  182. AML/eto‏‎ (1 revision)
  183. Frequent flyer‏‎ (1 revision)
  184. Tolerance dose‏‎ (1 revision)
  185. Attributable risk‏‎ (1 revision)
  186. Occupancy factor‏‎ (1 revision)
  187. ICRP Publication 101‏‎ (1 revision)
  188. Best available techniques‏‎ (1 revision)
  189. ICRP Publication 113‏‎ (1 revision)
  190. Bronchiolar region‏‎ (1 revision)
  191. ICRP Publication 128‏‎ (1 revision)
  192. ICRP Publication 142‏‎ (1 revision)
  193. Compartment‏‎ (1 revision)
  194. ICRP Publication 18‏‎ (1 revision)
  195. Cross section‏‎ (1 revision)
  196. ICRP Publication 30 (Part 1)‏‎ (1 revision)
  197. Deposition‏‎ (1 revision)
  198. ICRP Publication 39‏‎ (1 revision)
  199. Digital breast tomosynthesis‏‎ (1 revision)
  200. Relative risk‏‎ (1 revision)
  201. ICRP Publication 53‏‎ (1 revision)
  202. Ring chromosome‏‎ (1 revision)
  203. ICRP Supporting Guidance 2‏‎ (1 revision)
  204. ICRP Publication 68‏‎ (1 revision)
  205. ICRP Publication 82‏‎ (1 revision)
  206. International Commission on Radiological Protection‏‎ (1 revision)
  207. Excess absolute risk‏‎ (1 revision)
  208. Lag‏‎ (1 revision)
  209. Exposure pathway‏‎ (1 revision)
  210. Teratocarcinoma‏‎ (1 revision)
  211. Low dose‏‎ (1 revision)
  212. Functional subunits‏‎ (1 revision)
  213. Activity median aerodynamic diameter‏‎ (1 revision)
  214. Ground-level enhancement‏‎ (1 revision)
  215. ICRP Publication 101a‏‎ (1 revision)
  216. ICRP Publication 114‏‎ (1 revision)
  217. Potentially lethal damage repair‏‎ (1 revision)
  218. ICRP Publication 129‏‎ (1 revision)
  219. ICRP Publication 143‏‎ (1 revision)
  220. Compartment (environmental)‏‎ (1 revision)
  221. ICRP Publication 19‏‎ (1 revision)
  222. ICRP Publication 30 (Part 2)‏‎ (1 revision)
  223. ICRP Publication 4‏‎ (1 revision)
  224. Relative survival‏‎ (1 revision)
  225. ICRP Publication 54‏‎ (1 revision)
  226. ICRP Publication 69‏‎ (1 revision)
  227. ICRP Publication 83‏‎ (1 revision)
  228. Source region‏‎ (1 revision)
  229. Late normal tissue responses‏‎ (1 revision)
  230. Homologous recombination‏‎ (1 revision)
  231. Authorised discharge‏‎ (1 revision)
  232. Α/β value‏‎ (1 revision)
  233. Oncogene‏‎ (1 revision)
  234. ICRP Publication 101b‏‎ (1 revision)
  235. ICRP Publication 115‏‎ (1 revision)
  236. ICRP Publication 13‏‎ (1 revision)
  237. Clinical audit‏‎ (1 revision)
  238. ICRP Publication 144‏‎ (1 revision)
  239. ICRP Publication 2‏‎ (1 revision)
  240. ICRP Publication 30 (Part 3)‏‎ (1 revision)
  241. Derived consideration reference level‏‎ (1 revision)
  242. ICRP Publication 40‏‎ (1 revision)
  243. ICRP Publication 55‏‎ (1 revision)
  244. Dose conversion convention‏‎ (1 revision)
  245. ICRP Publication 7‏‎ (1 revision)
  246. Severe deterministic injury‏‎ (1 revision)
  247. ICRP Publication 84‏‎ (1 revision)
  248. Intervention‏‎ (1 revision)
  249. Exclusion‏‎ (1 revision)
  250. Sublethal damage repair‏‎ (1 revision)
  251. Acute exposure‏‎ (1 revision)
  252. Transfer of risk‏‎ (1 revision)
  253. Molecular imaging‏‎ (1 revision)
  254. Allometry‏‎ (1 revision)
  255. Noise‏‎ (1 revision)
  256. ΓH2AX foci‏‎ (1 revision)
  257. Operating management‏‎ (1 revision)
  258. ICRP Publication 102‏‎ (1 revision)
  259. Pencil beam‏‎ (1 revision)
  260. ICRP Publication 116‏‎ (1 revision)
  261. Practice‏‎ (1 revision)
  262. ICRP Publication 130‏‎ (1 revision)
  263. ICRP Publication 145‏‎ (1 revision)
  264. ICRP Publication 20‏‎ (1 revision)
  265. ICRP Publication 30 (Part 4)‏‎ (1 revision)
  266. Derived investigation level‏‎ (1 revision)
  267. ICRP Publication 41‏‎ (1 revision)
  268. Directional dose equivalent‏‎ (1 revision)
  269. ICRP Publication 56‏‎ (1 revision)
  270. Dose conversion factor‏‎ (1 revision)
  271. Risk model‏‎ (1 revision)
  272. ICRP Publication 70‏‎ (1 revision)
  273. Effect modifier‏‎ (1 revision)
  274. Sheltering‏‎ (1 revision)
  275. Induced genomic instability‏‎ (1 revision)
  276. ICRP Publication 85‏‎ (1 revision)
  277. Endosteum‏‎ (1 revision)
  278. Licensee‏‎ (1 revision)
  279. Thermodynamic diameter‏‎ (1 revision)
  280. Low linear energy transfer radiation‏‎ (1 revision)
  281. Nominal risk coefficient‏‎ (1 revision)
  282. Biological half-life‏‎ (1 revision)
  283. ICRP Publication 117‏‎ (1 revision)
  284. ICRP Publication 131‏‎ (1 revision)
  285. Quality control testing‏‎ (1 revision)
  286. ICRP Publication 146‏‎ (1 revision)
  287. Concentration ratio‏‎ (1 revision)
  288. Radioactive waste‏‎ (1 revision)
  289. ICRP Publication 21‏‎ (1 revision)
  290. ICRP Publication 30 (Supplement A to Part 3)‏‎ (1 revision)
  291. Derived limit‏‎ (1 revision)
  292. ICRP Publication 42‏‎ (1 revision)
  293. ICRP Publication 57‏‎ (1 revision)
  294. ICRPædia Guide to Radiological Protection in Healthcare‏‎ (1 revision - redirect page)
  295. ICRP Publication 71‏‎ (1 revision)
  296. Shielding‏‎ (1 revision)
  297. ICRP Publication 86‏‎ (1 revision)
  298. Superposition principle‏‎ (1 revision)
  299. Life Span Study‏‎ (1 revision)
  300. Thoracic airways‏‎ (1 revision)
  301. Multifactorial diseases‏‎ (1 revision)
  302. Nominal value‏‎ (1 revision)
  303. Human Alimentary Tract Model‏‎ (1 revision)
  304. ICRP Publication 104‏‎ (1 revision)
  305. Biomarker‏‎ (1 revision)
  306. ICRP Publication 132‏‎ (1 revision)
  307. Clonogenic surviving fraction‏‎ (1 revision)
  308. ICRP Publication 147‏‎ (1 revision)
  309. Cone beam computed tomography‏‎ (1 revision)
  310. ICRP Publication 22‏‎ (1 revision)
  311. Radon progeny‏‎ (1 revision)
  312. ICRP Publication 30 (Supplement B to Part 3)‏‎ (1 revision)
  313. Derived reference level‏‎ (1 revision)
  314. Reference parameter value‏‎ (1 revision)
  315. ICRP Publication 43‏‎ (1 revision)
  316. Disposal facility‏‎ (1 revision)
  317. ICRP Publication 58‏‎ (1 revision)
  318. ICRP Publication 72‏‎ (1 revision)
  319. ICRP Publication 87‏‎ (1 revision)
  320. Supervised area‏‎ (1 revision)
  321. Absorption Type‏‎ (1 revision - redirect page)
  322. Thoron progeny‏‎ (1 revision)
  323. Additional dose‏‎ (1 revision)
  324. Transgenerational effect‏‎ (1 revision)
  325. Ambient dose equivalent‏‎ (1 revision)
  326. Non-homologous end joining‏‎ (1 revision)
  327. Human Respiratory Tract Model‏‎ (1 revision)
  328. Automatic exposure control‏‎ (1 revision)
  329. Optimisation of protection‏‎ (1 revision)
  330. ICRP Publication 105‏‎ (1 revision)
  331. ICRP Publication 119‏‎ (1 revision)
  332. ICRP Publication 133‏‎ (1 revision)
  333. Quasi-threshold dose‏‎ (1 revision)
  334. ICRP Publication 148‏‎ (1 revision)
  335. Radiographer‏‎ (2 revisions)
  336. Representative organism (non-human biota)‏‎ (2 revisions)
  337. ICRPædia Guide to the Basics of Ionising Radiation‏‎ (2 revisions)
  338. Effective dose equivalent‏‎ (2 revisions)
  339. Existing exposure situation‏‎ (2 revisions)
  340. Threshold dose for tissue reactions‏‎ (2 revisions)
  341. Magnetosphere‏‎ (2 revisions)
  342. Gastroschisis‏‎ (2 revisions)
  343. Angiogenesis‏‎ (2 revisions)
  344. Hyperbaric oxygen‏‎ (2 revisions)
  345. Bioturbation‏‎ (2 revisions)
  346. Cardioverter-defibrillator‏‎ (2 revisions)
  347. Consequential late effects‏‎ (2 revisions)
  348. DRL value‏‎ (2 revisions)
  349. Representative person‏‎ (2 revisions)
  350. Safety‏‎ (2 revisions)
  351. Epithelium‏‎ (2 revisions)
  352. Specific effective energy‏‎ (2 revisions)
  353. Limitation of dose‏‎ (2 revisions)
  354. Acceptance test‏‎ (2 revisions)
  355. Gastrulation‏‎ (2 revisions)
  356. Transmission detection system‏‎ (2 revisions)
  357. Multistage tumorigenesis‏‎ (2 revisions)
  358. Habitual mouth breather‏‎ (2 revisions)
  359. Annihilation photons‏‎ (2 revisions)
  360. Non-sphericity parameter‏‎ (2 revisions)
  361. Hyperfractionation‏‎ (2 revisions)
  362. Bone marrow‏‎ (2 revisions)
  363. Pharynx‏‎ (2 revisions)
  364. Cohort study‏‎ (2 revisions)
  365. Containment‏‎ (2 revisions)
  366. Dose-length product‏‎ (2 revisions)
  367. Reproductive integrity‏‎ (2 revisions)
  368. Safety case‏‎ (2 revisions)
  369. Slow repair‏‎ (2 revisions)
  370. Equieffective dose‏‎ (2 revisions)
  371. Isotropic geometry‏‎ (2 revisions)
  372. Expanded and aligned radiation field‏‎ (2 revisions)
  373. Lineal energy‏‎ (2 revisions)
  374. Thyroid blocking‏‎ (2 revisions)
  375. Adventitious‏‎ (2 revisions)
  376. Transparency‏‎ (2 revisions)
  377. Habitual nose breather‏‎ (2 revisions)
  378. Waste disposal‏‎ (2 revisions)
  379. Non-targeted effects‏‎ (2 revisions)
  380. Hypertrophic cardiomyopathy‏‎ (2 revisions)
  381. Background dose (rate)‏‎ (2 revisions)
  382. Procedural values‏‎ (2 revisions)
  383. Reasonableness‏‎ (2 revisions)
  384. Detriment‏‎ (2 revisions)
  385. Dose-rate effect‏‎ (2 revisions)
  386. Residual dose‏‎ (2 revisions)
  387. Safety culture‏‎ (2 revisions)
  388. Electron-capture decay‏‎ (2 revisions)
  389. Solar cosmic radiation‏‎ (2 revisions)
  390. Inhalability‏‎ (2 revisions)
  391. Spontaneous fission‏‎ (2 revisions)
  392. Itinerant (radiation) worker‏‎ (2 revisions)
  393. Linear-non-threshold model‏‎ (2 revisions)
  394. Fluoroscopically or computed tomography guided interventions‏‎ (2 revisions)
  395. Trapped particles‏‎ (2 revisions)
  396. Hypoplasia‏‎ (2 revisions)
  397. Backscatter detection system‏‎ (2 revisions)
  398. Orphan source‏‎ (2 revisions)
  399. Bradycardia‏‎ (2 revisions)
  400. Planned exposure situation‏‎ (2 revisions)
  401. Progenitor cell‏‎ (2 revisions)
  402. Radiation belt‏‎ (2 revisions - redirect page)
  403. Coronary heart disease‏‎ (2 revisions)
  404. Radiological protection principles‏‎ (2 revisions)
  405. Decay constant‏‎ (2 revisions)
  406. Respiratory protection‏‎ (2 revisions)
  407. Dose of record Hp (10)‏‎ (2 revisions)
  408. Scintigraphy‏‎ (2 revisions)
  409. Electrophysiology‏‎ (2 revisions)
  410. Solar cycle‏‎ (2 revisions)
  411. Inner bremsstrahlung‏‎ (2 revisions)
  412. Systemic model‏‎ (2 revisions)
  413. Linear-quadratic dose response model‏‎ (2 revisions)
  414. Accreditation‏‎ (2 revisions)
  415. Time factor‏‎ (2 revisions)
  416. Genomic integrity‏‎ (2 revisions)
  417. Myocardial perfusion‏‎ (2 revisions)
  418. Hazard‏‎ (2 revisions)
  419. What is Radon?‏‎ (2 revisions)
  420. Bragg peak‏‎ (2 revisions)
  421. Platelet-derived growth factor‏‎ (2 revisions)
  422. Radiation modifier‏‎ (2 revisions)
  423. Cosmic Radiation in Aviation‏‎ (2 revisions)
  424. Radionuclides of natural origin‏‎ (2 revisions)
  425. Decommissioning‏‎ (2 revisions)
  426. Recovery (cellular or tissue)‏‎ (2 revisions)
  427. Dose-threshold‏‎ (2 revisions)
  428. Retrievability‏‎ (2 revisions)
  429. Immune system‏‎ (2 revisions)
  430. Institutional control‏‎ (2 revisions)
  431. Stakeholder‏‎ (2 revisions)
  432. Tachycardia‏‎ (2 revisions)
  433. Fractional absorption in the gastrointestinal tract‏‎ (2 revisions)
  434. Action Level‏‎ (2 revisions)
  435. Tissue equivalent material‏‎ (2 revisions)
  436. Myocardial stress test‏‎ (2 revisions)
  437. Health Surveillance‏‎ (2 revisions)
  438. Basal cell‏‎ (2 revisions)
  439. Oversight‏‎ (2 revisions)
  440. Branching fraction‏‎ (2 revisions)
  441. Chronic exposure‏‎ (2 revisions)
  442. Projected dose‏‎ (2 revisions)
  443. Colony‏‎ (2 revisions)
  444. Radioresponsiveness‏‎ (2 revisions)
  445. Decontamination‏‎ (2 revisions)
  446. Recovery responder‏‎ (2 revisions)
  447. Diastasis‏‎ (2 revisions)
  448. Reversibility‏‎ (2 revisions)
  449. Dose per unit intake coefficient‏‎ (2 revisions)
  450. In vivo radiobioassay‏‎ (2 revisions)
  451. Emergency‏‎ (2 revisions)
  452. Solar particle event‏‎ (2 revisions)
  453. Exposure, external or internal‏‎ (2 revisions)
  454. Graft vs host disease‏‎ (2 revisions)
  455. Air-kerma, incident‏‎ (2 revisions)
  456. Heliosphere‏‎ (2 revisions)
  457. Worker‏‎ (2 revisions)
  458. Nuclear track detectors‏‎ (2 revisions)
  459. Class SR-0 gases‏‎ (2 revisions)
  460. Radiation safety officer‏‎ (2 revisions)
  461. Cost-benefit analysis‏‎ (2 revisions)
  462. Radiosensitiser‏‎ (2 revisions)
  463. Decontamination factor‏‎ (2 revisions)
  464. Rehabilitation of living conditions‏‎ (2 revisions)
  465. Right to know‏‎ (2 revisions)
  466. Dose rate‏‎ (2 revisions)
  467. Incidence‏‎ (2 revisions)
  468. Emergency exposure situation‏‎ (2 revisions)
  469. Solar wind‏‎ (2 revisions)
  470. Erythropoietin‏‎ (2 revisions)
  471. Exposure (in the context of inhalation)‏‎ (2 revisions)
  472. Target tissue‏‎ (2 revisions)
  473. Fractionation and dose delivery patterns‏‎ (2 revisions)
  474. Measuring and Reducing Radon Levels in your Home‏‎ (2 revisions)
  475. Working level‏‎ (2 revisions)
  476. OLINDA/EXM‏‎ (2 revisions)
  477. Particle radiance‏‎ (2 revisions)
  478. Broad beam therapy irradiation technique‏‎ (2 revisions)
  479. Class SR-1 gases‏‎ (2 revisions)
  480. Protection strategy‏‎ (2 revisions)
  481. Committed effective dose‏‎ (2 revisions)
  482. Radiation source‏‎ (2 revisions)
  483. Radiosensitivity, cellular‏‎ (2 revisions)
  484. Dichotomous‏‎ (2 revisions)
  485. Rigidity‏‎ (2 revisions)
  486. Dose rate effectiveness factor‏‎ (2 revisions)
  487. Security‏‎ (2 revisions)
  488. Incident‏‎ (2 revisions)
  489. Emergency plan‏‎ (2 revisions)
  490. Intermediate level waste‏‎ (2 revisions)
  491. Ethics‏‎ (2 revisions)
  492. Stenosis‏‎ (2 revisions)
  493. ALARA‏‎ (2 revisions)
  494. Local DRL‏‎ (2 revisions)
  495. Tolerability‏‎ (2 revisions)
  496. Medical exposure‏‎ (2 revisions)
  497. Naturally occurring radioactive material‏‎ (2 revisions)
  498. Hierarchical tissues‏‎ (2 revisions)
  499. Area monitoring‏‎ (2 revisions)
  500. Working level month‏‎ (2 revisions)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)